Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Evaluation of warfarin (W) patient information

Authors: B. Bartle, A. Diamantouros, W. Geerts, L. Kim

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Excerpt

Background Adverse patient events post-discharge have been linked to poor communication between patients and practitioners. A common setting where patients receive written communication is their community pharmacy. The quality of written patient drug information has rarely been assessed with systematic methods. Aim This study was conducted to determine the accuracy of W patient information sheets using the consensus-based information website of the Thrombosis Interest Group of Canada (TIG) as a ‘gold standard’. In addition, the reading level of each information sheet was assessed and compared against the national literary standard. Methods Surveys were sent to the 47 members of the TIG to establish a consensus of important items for inclusion into a W information sheet. W patient information sheets/booklets distributed by Ontario (On) community pharmacies were collected and evaluated against the standard by 3 of the investigators. The reading level was assessed using 2 standarndized formulae, the Flesch-Kincaid and SMOG scales. Results The consensus created a checklist of 50 essential of important items against which the pharmacy sheets were compared. W information sheets representing 97% of On community pharmacies were analyzed. On average, W information sheets contained 40% of the necessary information while booklets produced by manufacturers of W contained on average 75% of the necessary information. Many of the W information sheets contained incorrect information. The average reading level of these sources of W information was a grade 10 level. Conclusions Sources of W information distributed by On pharmacies fail to fully address all the essential information required, and W information sheets contain incorrect information. Most of the information is written above the average reading level of adult Canadians. Implications Patient drug information sheets require input from practitioners who manage patients on the drug(s) in question. Other drug information sheets should be evaluated in a similar manner. …
Metadata
Title
Evaluation of warfarin (W) patient information
Authors
B. Bartle
A. Diamantouros
W. Geerts
L. Kim
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0145-2

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.